Pandeia Therapeutics
Research - Oxford, England, United Kingdom
Pandeia Therapeutics Employees
Pandeia Therapeutics Details
Pandeia Therapeutics is an Oxford based, venture backed startup.Pandeia is developing first in class GPR88 agonists for the treatment of motor symptoms associated with Huntington's Disease (HD).GPR88 has strong genetic validation as a target for HD, as well as other CNS disorders.Pandeia molecules have shown a superior efficacy and side effect profile to current standard of care in animal models of HD.Pandeia anticipates nominating a development candidate in 1H 2022.
Website:
http://www.pandeiatx.com
Employees:
2
HQ:
Location:
Oxford, England, United Kingdom
Revenue:
Pandeia Therapeutics Technologies
Email Providers
Outlook
CMS
WordPress.org
Fonts
Google Font API
Other
Mobile Friendly